“Omalizumab In The Treatment Of Refractory Urticarial Vasculitis Triggered By SARS-Cov-2 Infection: A Pediatric Case Report”, Dermatol Pract Concept, vol. 14, no. 4, p. e2024252, Oct. 2024, doi: 10.5826/dpc.1404a252.